Page last updated: 2024-10-31

naratriptan and Complications, Pregnancy

naratriptan has been researched along with Complications, Pregnancy in 2 studies

naratriptan: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Using the Marketscan database, the risk of major birth defects was ascertained in live-born infants whose birth mothers were exposed to sumatriptan, naratriptan, or sumatriptan/naproxen during pregnancy."3.88Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study. ( Bollinger, L; Cangialose, C; Chia, V; Mikol, DD; Xue, F; Yusuf, A, 2018)
"Accumulated data suggest that exposure to sumatriptan during pregnancy does not increase the risk of birth defects above the baseline rate."3.76Safety of triptans for migraine headaches during pregnancy and breastfeeding. ( Bozzo, P; Duong, S; Einarson, A; Nordeng, H, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yusuf, A1
Chia, V1
Xue, F1
Mikol, DD1
Bollinger, L1
Cangialose, C1
Duong, S1
Bozzo, P1
Nordeng, H1
Einarson, A1

Other Studies

2 other studies available for naratriptan and Complications, Pregnancy

ArticleYear
Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.
    Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:12

    Topics: Abnormalities, Drug-Induced; Administrative Claims, Healthcare; Adolescent; Adult; Databases, Factua

2018
Safety of triptans for migraine headaches during pregnancy and breastfeeding.
    Canadian family physician Medecin de famille canadien, 2010, Volume: 56, Issue:6

    Topics: Breast Feeding; Female; Humans; Migraine Disorders; Piperidines; Pregnancy; Pregnancy Complications;

2010